Literature DB >> 15004502

The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow.

Ozgül Altintaş1, Yusuf Caglar, Nurşen Yüksel, Ali Demirci, Levent Karabaş.   

Abstract

OBJECTIVE: To evaluate the effects of menopause and hormone replacement therapy (HRT) on the quality and amount of tear, intraocular pressure (IOP) and retrobulbar blood flow velocities. PATIENTS AND METHODS: Twenty women aged between 40 and 50 years, free of ocular and systemic diseases and planning to receive HRT were recruited as the study group. Twenty-four healthy, age-matched but still menstruating women were enrolled as controls. On the first day of study basal and reflex Schirmer test, tear break-up time and IOP measurements (at 08.00, 12.00 and 16.00 h) were performed for all groups. On the second day of the study, the peak systolic velocity (PSV), end diastolic velocity (EDV) and resistivity index (RI) of the ophthalmic (OA), central retinal (CRA), nasal (NSPCA) and temporal short posterior ciliary (TSPCA) arteries were determined by color Doppler imaging. The menopausal group received HRT for 2 months, when all measurements were repeated for the 15 women who had received HRT on a daily basis.
RESULTS: The quality and amount of tear decreased (p < 0.01), IOP (p < 0.01) and RI of the CRA, TPCA and NPCA (p < 0.05) increased in postmenopausal women compared with the control group. After 2 months of HRT, the quality and amount of tear had increased (p < 0.001) and the IOP had decreased (p < 0.001). The PSV of the CRA and TSPCA had decreased (p < 0.05), as had the RI in the CRA (p < 0.001), NSPCA and TSPCA (p < 0.05).
CONCLUSION: We conclude that age-induced changes on quality and amount of tear, IOP and retrobulbar blood flow are intensified by the menopause and that it may be possible to decrease the menopausal effects on these parameters by HRT. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004502     DOI: 10.1159/000076148

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  34 in total

1.  Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA.

Authors:  Janey L Wiggs; Jae Hee Kang; Brian L Yaspan; Daniel B Mirel; Cathy Laurie; Andrew Crenshaw; Wendy Brodeur; Stephanie Gogarten; Lana M Olson; Wael Abdrabou; Elizabeth DelBono; Stephanie Loomis; Jonathan L Haines; Louis R Pasquale
Journal:  Hum Mol Genet       Date:  2011-08-26       Impact factor: 6.150

2.  The effect of intramuscular dexmedetomidine-butorphanol combination on tear production in dogs.

Authors:  Fabio Leonardi; Giovanna Lucrezia Costa; Alice Stagnoli; Elena Zubin; Paolo Boschi; Alberto Sabbioni; Barbara Simonazzi
Journal:  Can Vet J       Date:  2019-01       Impact factor: 1.008

3.  A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.

Authors:  Jae H Kang; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

4.  The potential association between postmenopausal hormone use and primary open-angle glaucoma.

Authors:  Paula Anne Newman-Casey; Nidhi Talwar; Bin Nan; David C Musch; Louis R Pasquale; Joshua D Stein
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

5.  Effects of estrogen replacement therapy on apoptosis and vascular endothelial growth factor expression in ocular surface epithelial cells: An experimental study.

Authors:  Fatih Ozcura; Sema Oruç Dündar; Emel Dikicioğlu Cetin; Nahit Beder; Mehmet Dündar
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

6.  Sex hormone levels and risk of primary open-angle glaucoma in postmenopausal women.

Authors:  Jae Hee Kang; Bernard A Rosner; Janey L Wiggs; Louis R Pasquale
Journal:  Menopause       Date:  2018-10       Impact factor: 2.953

Review 7.  Is Estrogen a Therapeutic Target for Glaucoma?

Authors:  Samantha S Dewundara; Janey L Wiggs; David A Sullivan; Louis R Pasquale
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

Review 8.  Gender and glaucoma: what we know and what we need to know.

Authors:  Thasarat S Vajaranant; Sushma Nayak; Jacob T Wilensky; Charlotte E Joslin
Journal:  Curr Opin Ophthalmol       Date:  2010-03       Impact factor: 3.761

Review 9.  Contribution of the Nurses' Health Study to the Epidemiology of Cataract, Age-Related Macular Degeneration, and Glaucoma.

Authors:  Jae H Kang; Juan Wu; Eunyoung Cho; Soshiro Ogata; Paul Jacques; Allen Taylor; Chung-Jung Chiu; Janey L Wiggs; Johanna M Seddon; Susan E Hankinson; Debra A Schaumberg; Louis R Pasquale
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

10.  The effects of raloxifene hydrochloride on ocular hemodynamics and visual function.

Authors:  Brent Siesky; Alon Harris; Nisha Kheradiya; Rita Ehrlich; Carissa Klaas; Boaris Kaplan; Yara Catoira; Lynne McCranor; Carlos Rospigliosi; Mira Harris
Journal:  Int Ophthalmol       Date:  2008-04-22       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.